VLA
Click for more information
0.00% $1.75 viralytics limited

cavatak's coxsackie a virus - further patent

  1. PeterFred
    735 Posts.
    lightbulb Created with Sketch. 1806
    clock Created with Sketch.
    15/02/12
    10:22
    Post #: 9695217
    This development widens the scope for CAVATAKtm, whose various forms can now can be used to attack cancer cells expressing either ICAM-1 or DAF (delay accelerating factor). I wonder what further developments in the Viralytics labs will emerge - the first we'll hear will be annoouncments of patent grants. Very encouraging news.
    VLA Price at posting: 38.2¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
NEWS ASX explains: How 'futures' are predicted
right-arrow Created with Sketch.
GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
STX Strike hits "significant" 28m of net gas pay downhole Australia's deepest ever gas well; extends system east
right-arrow Created with Sketch.
GED Golden Deeps sniffs 80-metre-long copper and zinc sulphide zone at NSW's Havilah
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.